Qube Research & Technologies LTD Chroma Dex Corp. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.36 - $3.84 $14,218 - $40,147	-10,455 Reduced 7.93%	121,339 $422,000
Q4 2023 Feb 13, 2024	BUY	$1.28 - $1.6 $152,555 - $190,694	119,184 Added 945.15%	131,794 $188,000
Q3 2023 Nov 13, 2023	BUY	$1.36 - $1.77 $17,149 - $22,319	12,610 New	12,610 $18,000
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $6,189 - $10,714	-5,201 Reduced 11.62%	39,570 $49,000
Q2 2022 Aug 15, 2022	BUY	$1.59 - $2.7 $71,185 - $120,881	44,771 New	44,771 $75,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $360M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.